4Z4-33261-09524
4 vaccinations
3 coded responses
32 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2021-02-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-16
Registered in v-safe
-
2021-02-16
Dose 1 — Pfizer-BioNTech
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
-
2021-02-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-02-22
- 2021-02-23
- 2021-03-02
- 2021-03-09
-
2021-03-10
Dose 2 — Pfizer-BioNTech
-
2021-03-10
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Fever · Fatigue or tirednessAdult check-in
-
2021-03-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-12
-
2021-03-13
Survey response — days 1–6 daily, dose 2MedDRA: Menstruation delayed — Feeling: GoodFree text: My period was 2 days later than normal.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-14
- 2021-03-15
-
2021-03-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-06-09
- 2021-09-08
-
2021-11-17
Dose 3 — Pfizer-BioNTech
- 2021-12-12
- 2021-12-15
-
2021-12-22
Survey response — day 35, dose 3MedDRA: Abortion spontaneous, Office visit — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professionalFree text: Symptoms: Miscarried baby. · Healthcare visit (other): Went to our fertility clinic.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-22
Report sent to call center — day 35, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-12-27
- 2022-02-18
- 2022-05-18
-
2022-10-17
Dose 4 — Pfizer-BioNTechCo-administered: Tetanus
- 2022-11-17
- 2023-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-16 | Pfizer-BioNTech | |
| 2 | 2021-03-10 | Pfizer-BioNTech | |
| 3 | 2021-11-17 | Pfizer-BioNTech | No |
| 4 | 2022-10-17 | Pfizer-BioNTech | Tetanus |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-22 | Unsuccessful |
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): My period was 2 days later than normal.
Release 10 — day 35, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Menstruation delayed | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release